Search Within

Josef J Fox

  1. "Heiko Schoder"
Formats
  1. Journal Article (17)
  2. Meeting Abstract (16)
Groups
  1. Molecular Imaging and Therapy Service (33)
  2. Radiology, Department of (33)
  3. Department of Medicine (27)
  4. GSK Faculty (22)
  5. Molecular Pharmacology and Chemistry Program Faculty (20)
  6. Sloan Kettering Institute Faculty (20)

More Groups

People
  1. Heiko Schoder (33)
  2. Steven Larson (19)
  3. Howard Scher (15)
  4. Michael Morris (15)
  5. John Humm (10)
  6. Eric Haupt (6)

More People

Years
  1. 2024 (2)
  2. 2023 (1)
  3. 2022 (2)
  4. 2021 (1)
  5. 2020 (3)
  6. 2018 (1)

More Years

Publications
  1. Journal of Clinical Oncology (12)
  2. Journal of Nuclear Medicine (5)
  3. International Journal of Radiation Oncology, Biology, Physics (4)
  4. Clinical Cancer Research (2)
  5. Acta Oncologica (1)
  6. American Journal of Roentgenology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (12)
  2. Elsevier Inc. (5)
  3. Society of Nuclear Medicine (5)
  4. American Association for Cancer Research (2)
  5. Lippincott Williams & Wilkins (2)
  6. American College of Chest Physicians (1)

More Publishers

Results (33)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A pilot study of cardiac (13)N-ammonia PET imaging to assess early cardiotoxicity following multibeam intensity-modulated radiation therapy for breast cancer
    Meeting Abstract

    Nehmeh, S. A.; Fox, J. J.; Schwartz, J.; Ballangrud, A.; Schoder, H.; Strauss, H. W.; Yu, A.; Gupta, D.; Hwang, K.; Powell, S. N.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Rest and stress Rb-82 PET myocardial perfusion imaging as a predictor of perioperative cardiac events in cancer patients
    Meeting Abstract

    Fox, J.; Gupta, D.; Yu, A.; Gandikota, N.; Larson, S.; Schoder, H.; Strauss, H. W.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • Pediatric bone sarcoma: Diagnostic performance of (18)F-FDG PET/CT versus conventional imaging for initial staging and follow-up
    Journal Article

    Quartuccio, N.; Fox, J.; Kuk, D.; Wexler, L. H.; Baldari, S.; Cistaro, A.; Schoder, H.
    American Journal of Roentgenology (2015)

    Fulltext@MSK | Save
  • Pathologic correlation of 18F-16 beta-fluoro-5 alpha-dihydrotestosterone (FDHT) and FDG PET in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Feldman, J. L.; Fox, J. J.; Martinez, D. F.; Autio, K. A.; Durack, J. C.; Humm, J.; Schoder, H.; Gavane, S. C.; Curtis, K. R.; Balakirsky, S. M.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Predicting outcome in patients with rhabdomyosarcoma: Role of [18F]fluorodeoxyglucose positron emission tomography
    Journal Article

    Casey, D. L.; Wexler, L. H.; Fox, J. J.; Dharmarajan, K. V.; Schoder, H.; Price, A. N.; Wolden, S. L.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Evaluating 18F-16 beta-fluoro-5 alpha-dihydrotestosterone (FDHT) and FDG PET as prognostic biomarkers for patients (pts) treated with abiraterone acetate (AA)
    Meeting Abstract

    Feldman, J. L.; Fox, J. J.; Autio, K. A.; Gavane, S. C.; Heller, G.; Schoder, H.; Humm, J.; Martinez, D. F.; Slovin, S. F.; Scher, H. I.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Noncontrast perfusion single-photon emission CT/CT scanning: A new test for the expedited, high-accuracy diagnosis of acute pulmonary embolism
    Journal Article

    Lu, Y.; Lorenzoni, A.; Fox, J. J.; Rademaker, J.; Els, N. V.; Grewal, R. K.; Strauss, H. W.; Schöder, H.
    Chest (2014)

    Fulltext@MSK | Save
  • Post-treatment alterations in 18F-dihydrotestosterone (FDHT) and FDG PET/CT in metastatic castration-resistant prostate cancer (mCRPC) treated with cabozantinib
    Meeting Abstract

    Fox, J. J.; Haupt, E. C.; Humm, J.; Autio, K. A.; Rathkopf, D. E.; Vargas, H. A.; Schöder, H.; Hricak, H.; Larson, S. M.; Scher, H. I.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Evaluating 18F-16B-fluoro-5α-dihydrotestosterone (FDHT) and FDG-PET as a measure of disease progression in metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Autio, K. A.; Fox, J. J.; Schneider, C. W.; Schöder, H.; Humm, J.; Rathkopf, D. E.; Slovin, S. F.; Danila, D. C.; Haupt, E. C.; Larson, S. M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • 18F-16 beta-fluoro-5 alpha-dihydrotestosterone (FDHT) PET as a prognostic biomarker for survival in patients with metastatic castrate-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Autio, K. A.; Fox, J. J.; Jia, X.; Heller, G.; Schoder, H.; Humm, J.; Haupt, E. C.; Schneider, C.; Scher, H. I.; Larson, S. M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save